• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    66.37 Down 1.38(2.03%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:67.75
    Open:67.49
    Bid:65.40 x 500
    Ask:67.24 x 500
    1y Target Est:65.80
    Beta:1.32
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:66.20 - 68.15
    52wk Range:22.25 - 77.80
    Volume:1,751,749
    Avg Vol (3m):2,766,120
    Market Cap:7.90B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 2.03%7.90B
    ENZDown 0.66%136.58M
    GILDDown 1.44%153.79B
    SRPTDown 1.76%554.97M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):37.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.83
    Quarterly EPS Est (Mar-15) :-0.21
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-3.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback